Psychotropic medication in children and adolescents in Germany: Prevalence, indications, and psychopathological patterns

Journal of Child and Adolescent Psychopharmacology

Volumn 19, Issue 6, 2009, Pages 765-770

  Koelch, M ^a   Prestel, A ^a   Singer, H ^a   Keller, F ^a   Fegert, J M ^a   Schlack, R ^b   Hoelling, H ^b   Knopf, H ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; FLUVOXAMINE; IMIPRAMINE; MELATONIN; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SEDATIVE AGENT; TIAPRIDE;

ADOLESCENT; ARTICLE; BEHAVIOR DISORDER; CHILD; DEPRESSION; DRUG INDICATION; DRUG USE; EMOTIONAL DISORDER; FEMALE; GERMANY; HEALTH SURVEY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEWBORN; OBSESSIVE COMPULSIVE DISORDER; PARENT; PRESCHOOL CHILD; PRESCRIPTION; PREVALENCE; PSYCHOLOGIC TEST; SCHOOL CHILD; SCREENING TEST; SEIZURE; SELF MEDICATION; SLEEP DISORDER; TIC; TREATMENT DURATION;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; GERMANY; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENTAL DISORDERS; OFF-LABEL USE; PHYSICIAN'S PRACTICE PATTERNS; POPULATION SURVEILLANCE; PREVALENCE; PSYCHOPATHOLOGY; PSYCHOTROPIC DRUGS; SELF MEDICATION; SEX FACTORS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 77049126641     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2009.0018     Document Type: Article

References (24)

1. Alacqua M, Trifiro G, Arcoraci V, Germano E, Magazu A, Calarese T, Di Vita G, Gagliano C, Spina E: Use and tolerability of newer antipsychotics and antidepressants: A chart review in a paediatric setting. Pharm World Sci 30:44-50, 2008. Epub June 21, 2007.
2. Bucheler R, Schwab M, Morike K, Kalchthaler B, Mohr H, Schroder H, Schwoerer P, Gleiter CH: Off label prescribing to children in primary care in Germany: Retrospective cohort study. BMJ 324: 1311-1312, 2002.
3. Cala S, Crimson ML, Baumgartner J: A survey of herbal use in children with attention-deficit-hyperactivity disorder or depression. Pharmacotherapy 23:222-230, 2003.
4. Cooper WO, Hickson GB, Fuchs C, Arbogast PG, Ray WA: New users of antipsychotic medications among children enrolled in TennCare. Arch Pediatr Adolesc Med, 158:753-759, 2004.
5. Goodman R: The Strengths and Difficulties Questionnaire: A research note. J Child Psychol Psychiatry 38:581-586, 1997.
6. Goodman R: Psychometric properties of the Strengths and Difficulties Questionnaire (SDQ). J Am Acad Child AdolescPsychiatry 40:1337-1345, 2001.
7. Hack S, Chow B: Pediatric psychotropic medication compliance: A literature review and research-based suggestions for improving treatment compliance. J Child Adolesc Psychopharmacol 11:59-67, 2001.
8. Harrison CM, Britt HC: Antidepressant use in children: A less depressing story. Med J Aust 182:92, 2005.
9. Holling H, Erhart M, Ravens-Sieberer U, Schlack R: [Behavioural problems in children and adolescents. First results from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 50:784-793, 2007.
10. Hwang B, Cosby A, Laberge ME: Compliance with three-time daily methylphenidate in children with attention deficit/hyperactivity disorder. Value in Health 6:273, 2003.
11. Kamtsiuris P, Lange M, Schaffrath Rosario A: [The German Health Interview and Examination Survey for Children and Adolescents (KiGGS): Sample design, response and nonresponse analysis]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 50:547-556, 2007.
12. Knopf H: [Medicine use in children and adolescents. Data collection and first results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 50:863-870, 2007.
13. Kurth BM, Kamtsiuris P, Holling H, Schlaud M, Dolle R, Ellert U, Kahl H, Knopf H, Lange M, Mensink GB, Neuhauser H, Rosario AS, Scheidt-Nave C, Schenk L, Schlack R, Stolzenberg H, Thamm M, Thierfelder W, Wolf U: The challenge of comprehensively mapping children's health in a nation-wide health survey: Design of the German KiGGS-Study. BMC Public Health 8:196, 2008.
14. Mathai J, Anderson P, Bourne A: The Strengths and Difficulties Questionnaire (SDQ) as a screening measure prior to admission to a Child and Adolescent Mental Health Service (CAMHS). Australian e-Journal for the Advancement of Mental Health 1, 2002.
15. Mathai J, Anderson P, Bourne A: Comparing psychiatric diagnoses generated by the Strengths and Difficulties Questionnaire with diagnoses made by clinicians. Aust N Z J Psychiatry 38:639-643, 2004.
16. McCann JB, James A, Wilson S, Dunn G: Prevalence of psychiatric disorders in young people in the care system. BMJ 313:1529-1530, 1996.
17. Muris P, Meesters C, Van Den Berg F: The Strengths and Difficulties Questionnaire (SDQ): Further evidence for its reliability and validity in a community sample of Dutch children and adolescents. Eur Child Adolesc Psychiatry 12:1-8, 2003. (Pubitemid 36336854)
18. Ohayon MM, Lader MH: Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 63:817-825, 2002.
19. Schmid M, Goldbeck L, Nuetzel J, Fegert JM: Prevalence of mental disorders among adolescents in German youth welfare institutions. Child Adolesc Psychiatry Ment Health 2:2, 2008.
20. Van Rijswijk E, Borghuis M, Van De Lisdonk E, Zitman F, Van Weel C: Treatment of mental health problems in general practice: A survey of psychotropics prescribed and other treatments provided. Int J Clin Pharmacol Ther 45:23-29, 2007.
21. Volkers AC, Heerdink ER, Van Dijk L: Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005). Pharmacoepidemiol Drug Safe 16:1054-1062, 2007.
22. Winkler J, Stolzenberg H: [Social class index in the Federal Health Survey]. Gesundheitswesen 61 Spec No, S178-S183, 1999.
23. Zito JM, Tobi H, De Jong-Van Den Berg LT, Fegert JM, Safer D, Janhsen K, Hansen DG, Gardner JF, Glaeske G: Antidepressant prevalence for youths: A multi-national comparison. Pharmacoepidemiol Drug Safe 15:793-798, 2006.
24. Zito JM, Safer DJ, Janhsen K, Fegert JM, Gardner JF, Glaeske G, Valluri SC: A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health 2:26, 2008.